Juvenile limb-girdle muscular dystrophy

Michel Fardeau, Dominique Hillaire, C. Mignard, +8

Brain

Rare DiseasesKinesiologyMendelian DisorderSkeletal MuscleGenetic Disorder +13

Chromosome 15-linked limb-girdle muscular dystrophy: Clinical phenotypes in Reunion Island and French metropolitan communities

Michel Fardeau, B. Eymard, C. Mignard, +3

Neuromuscular Disorders

French Metropolitan CommunitiesGenetic DisorderGeneticsClinical PhenotypesDegenerative Disease +5

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma

C. Mignard, Aurélie Deschamps Huvier, André Gillibert, +29

Journal of Oncology

Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy

C. Mignard, Maud Maho‐Vaillant, Marie-Laure Golinski, +34

JAMA Dermatology

Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus

Maud Maho‐Vaillant, Corine Pérals, Marie-Laure Golinski, +11

Journal of Investigative Dermatology

Desmoglein-specific B CellsAutoimmune DiseaseLymphocyte DevelopmentImmune RegulationImmunology +4

Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first‐line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial

V. Hébert, Thomas Vermeulin, L Tanguy, +4

British Journal of Dermatology

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy

Billal Tedbirt, Maud Maho‐Vaillant, Estelle Houivet, +34

JAMA Dermatology

Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma

C. Mignard, A. Deschamps-Huvier, A.-B. Duval-Modeste, +16

Annals of Oncology

Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib

Camille Pinard, C. Mignard, A Samain, +2

JAAD Case Reports